streptomycin has been researched along with Buruli Ulcer Disease in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (13.46) | 29.6817 |
2010's | 40 (76.92) | 24.3611 |
2020's | 5 (9.62) | 2.80 |
Authors | Studies |
---|---|
Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Zhang, T | 1 |
Aroso, I; Correlo, VM; Fraga, AG; Marques, AP; Mendes, AI; Pedrosa, J; Rebelo, R | 1 |
Akiyama, M; Constance, K; Kouadio, K; Murase, C; N'Golo, DC; N'guessan, K; N'Guetta, A; Vagamon, B; Yao, A; Yotsu, RR | 1 |
Johnson, PDR | 1 |
Abass, KM; Agossadou, D; Ampadu, EO; Asiedu, KB; Chauty, A; Egondi, TW; Frimpong, M; Ganlonon, L; Gateau, T; Grosset, J; Lehman, L; Macdonald, JM; Marion, E; Ochieng Otieno, M; Ohene, SA; Omollo, R; Paintsil, A; Phillips, RO; Robert, J; Saizonou, R; Sarfo, FS; Sarpong, G; Sarpong, NF; Saunderson, P; Stienstra, Y; Thompson, W; Tiendrebeogo, A; Treadwell, T; van der Werf, TS; Wansbrough-Jones, M; Wilson, T | 1 |
Abbass, A; Dzudzor, B; Gyamfi, E; Mosi, L; Narh, CA; Quaye, C | 1 |
Guarner, J | 1 |
Agbo, IE; Amoussouhoui, AS; Aoulou, P; Boyer, M; Houezo, JG; Johnson, RC; Nichter, M; Sopoh, GE; Wadagni, AC | 1 |
Ishii, N; Richardson, M; Yotsu, RR | 1 |
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J | 1 |
Almeida, DV; Converse, PJ; Grosset, JH; Li, SY; Nuermberger, EL; Tyagi, S | 1 |
Almeida, DV; Converse, PJ; Grosset, JH; Robinson, C; Sarfo, FS; Wansbrough-Jones, M; Zhang, J | 1 |
Anku, B; Asan-Ampah, K; Kpeli, GS; Kwakye-Maclean, C; Lamptey, I; Newman, M; Owusu-Mireku, E; Paintsil, A; Pluschke, G; Quenin-Fosu, K; Ruf, MT; Yeboah-Manu, D | 1 |
Abass, MK; Abotsi, J; Amoako, YA; Asiedu, K; Forson, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M; Wilson, T | 1 |
Abass, KM; Klis, S; Phillips, RO; Stienstra, Y; Tuah, W; van der Werf, TS | 1 |
Athan, E; Buntine, J; Callan, PP; Friedman, ND; Horne, S; Hughes, A; Jenkin, G; Johnson, PD; McDonald, A; O'Brien, DP; Steffen, CM | 1 |
Asiedu, KB; Babonneau, J; Kempf, M; Marion, E; Marsollier, L; Obvala, D | 1 |
Kingma, R; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS | 1 |
Abass, MK; Amoako, YA; Ampadu, E; Asiedu, K; Forson, M; Frimpong, M; Phillips, RO; Sarfo, FS; Thompson, W; Wansbrough-Jones, M | 1 |
Johnson, PD; Omansen, TF; Porter, JL; Stienstra, Y; Stinear, TP; van der Werf, TS | 1 |
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y | 1 |
Aboagye, S; Akuoku, V; Ampofo, W; Bonney, K; Kpeli, G; Owusu-Mireku, E; Paintsil, A; Pereko, J; Pluschke, G; Ruf, MT; Tuffour, J; Yeboah-Manu, D | 1 |
Adu, EJ; Ampadu, E | 1 |
Kingma, RA; Klis, S; Stienstra, Y; Tuah, W; van der Werf, TS | 1 |
Abass, KM; Agumah, E; de Zeeuw, J; Klis, S; Phillips, RO; Stienstra, Y; van der Werf, TS; Velink, A; Woolley, RJ | 1 |
Fernandez, RS; Tanywe, A | 1 |
Afari, EA; Anim, J; Antara, SN; Iddrisah, FN; Kenu, E; Nortey, PA; Nyarko, KM; Wurapa, F; Yeboah-Manu, D | 1 |
Anyo, G; Fraga, AG; Kibadi, K; Longatto Filho, A; Meyers, WM; Nakazawa, Y; Panda, M; Pedrosa, J; Portaels, F; Suykerbuyk, P; Tamfum, JJ | 1 |
Adentwe, E; Ampadu, E; Phillips, RO; Sarfo, FS; Sarpong, F; Wansbrough-Jones, M | 1 |
Pluschke, G; Schütte, D; Umboock, A | 1 |
Aubry, A; Chauffour, A; Ibrahim, M; Jarlier, V; Ji, B; Robert, J | 1 |
Hauck, FR; Houp, E; Portaels, F; Webb, BJ | 1 |
Abass, KM; Adjei, O; Ampadu, EO; Awua-Boateng, NY; Awuah, PC; Bretzel, G; Nienhuis, WA; Schouten, JP; Siegmund, V; Stienstra, Y; Thompson, WA; Tuah, W; van der Werf, TS | 1 |
Colebunders, R; Kibadi, K; Meyers, WM; Muyembe-Tamfum, JJ; Portaels, F | 1 |
Billal, DS | 1 |
Adentwe, E; Ampadu, E; Asiedu, K; Bobi, N; Lartey, A; Phillips, R; Sarfo, FS; Tetteh, I; Wansbrough-Jones, M | 1 |
Boelaert, M; Fraga, AG; Kayinua, M; Kibadi, K; Longatto-Filho, A; Meyers, WM; Minuku, JB; Mputu-Yamba, JB; Muyembe-Tamfum, JJ; Pedrosa, J; Portaels, F; Roux, JJ | 1 |
Affolabi, D; Anagonou, SY; Barogui, YT; Brun, LV; Dossou, AD; Houézo, JG; Johnson, RC; Kestens, L; Portaels, F; Sopoh, GE | 1 |
Milánkovits, M | 1 |
Adeye, A; Ardant, MF; Chauty, A; Johnson, RC; Koussemou, H; Pluschke, G; Ruf, MT | 1 |
Barogui, YT; Brun, LV; Dossou, AD; Johnson, RC; Pluschke, G; Ruf, MT; Sopoh, GE | 1 |
Almeida, DV; Converse, PJ; Grosset, JH; Nuermberger, EL | 1 |
Ampadu, ED; Asan-Ampah, K; Asante-Poku, A; Pluschke, G; Yeboah-Manu, D | 1 |
Chauffour, A; Jarlier, V; Ji, B; Pluschke, G; Ruf, MT; Schütte, D | 1 |
Castro, AG; Fraga, AG; Gama, JB; Martins, TG; Pedrosa, J; Saraiva, M; Silva, MT | 1 |
Yotsu, R | 1 |
Amekuse, K; Badziklou, K; Banla Kere, A; Beissner, M; Bretzel, G; Diefenhardt, A; Hoffmann, H; Jansson, M; Kobara, B; Löscher, T; Maman, I; Nitschke, J; Piten, E; Symank, D; Wiedemann, F | 1 |
Dehn, TC; Tsukagoshi, S | 1 |
Castro, AG; Fraga, AG; Gama, JB; Longatto-Filho, A; Martins, TG; Pedrosa, J; Saraiva, M; Silva, MT; Trigo, G | 1 |
Adeye, A; Ardant, MF; Aubry, J; Chauty, A; Euverte, H; Grosset, J; Guédénon, A; Johnson, C; Nuermberger, E | 1 |
Itin, P; Mensah-Quainoo, E; Pluschke, G; Schmid, P; Schütte, D; Um-Boock, A | 1 |
5 review(s) available for streptomycin and Buruli Ulcer Disease
Article | Year |
---|---|
Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.
Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Macrolides; Mycobacterium Infections; Mycobacterium ulcerans; Neglected Diseases; Polymerase Chain Reaction; Rifampin; Skin Diseases, Bacterial; Streptomycin | 2018 |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
Topics: Administration, Oral; Anti-Bacterial Agents; Buruli Ulcer; Drug Administration Schedule; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2017 |
Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era.
Topics: Africa, Western; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Early Diagnosis; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2009 |
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?
Topics: Adolescent; Animals; Anti-Bacterial Agents; Buruli Ulcer; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Young Adult | 2011 |
5 trial(s) available for streptomycin and Buruli Ulcer Disease
Article | Year |
---|---|
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benin; Buruli Ulcer; Child; Clarithromycin; Delayed-Action Preparations; Drug Therapy, Combination; Female; Ghana; Humans; Male; Rifampin; Streptomycin; Wound Healing; Young Adult | 2020 |
Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Audiometry; Buruli Ulcer; Child; Child, Preschool; Creatinine; Drug-Related Side Effects and Adverse Reactions; Female; Hearing Loss; Humans; Kidney Diseases; Male; Middle Aged; Streptomycin; Young Adult | 2014 |
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Ghana; Humans; Injections, Intramuscular; Leprostatic Agents; Male; Mycobacterium ulcerans; Rifampin; Statistics, Nonparametric; Streptomycin; Time Factors; Treatment Outcome; Young Adult | 2010 |
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.
Topics: Adolescent; Adult; Aged; Buruli Ulcer; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Young Adult | 2010 |
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Survival Analysis; Treatment Outcome | 2007 |
42 other study(ies) available for streptomycin and Buruli Ulcer Disease
Article | Year |
---|---|
Using bioluminescence to monitor treatment response in real time in mice with Mycobacterium ulcerans infection.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Female; Kanamycin; Luminescence; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin | 2011 |
Development of an antibiotics delivery system for topical treatment of the neglected tropical disease Buruli ulcer.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Humans; Hydrogels; Polyesters; Quality of Life; Rifampin; Streptomycin | 2022 |
Child case of Buruli ulcer successfully treated through a school-based skin survey project in Côte d'Ivoire.
Topics: Antibiotics, Antitubercular; Arm; Buruli Ulcer; Child; Cote d'Ivoire; Drug Therapy, Combination; Humans; Male; Mass Screening; Mycobacterium ulcerans; Neglected Diseases; Rifampin; School Health Services; Skin; Streptomycin; Treatment Outcome | 2020 |
Buruli ulcer: cured by 8 weeks of oral antibiotics?
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Humans; Rifampin; Streptomycin | 2020 |
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacillus; Bacteria; Buruli Ulcer; Candida; Clarithromycin; Coinfection; Cote d'Ivoire; Cross-Sectional Studies; Female; Fungi; Ghana; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillium; Staphylococcus; Streptomycin; Trichoderma; Watchful Waiting; Young Adult | 2021 |
Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.
Topics: Anti-Bacterial Agents; Benin; Buruli Ulcer; Community Health Services; Disease Management; Early Medical Intervention; Female; Health Impact Assessment; Health Plan Implementation; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin | 2018 |
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin | 2019 |
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans disease.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Viability; Mycobacterium ulcerans; Rifampin; Secondary Prevention; Streptomycin; Treatment Outcome | 2013 |
Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Cell Survival; Disease Models, Animal; Histocytochemistry; Macrolides; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin | 2013 |
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Buruli Ulcer; Child; Child, Preschool; Coinfection; Drug Resistance, Bacterial; Female; Ghana; Humans; Male; Middle Aged; Rifampin; Streptomycin; Wound Infection; Young Adult | 2013 |
Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Female; Ghana; Humans; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome | 2014 |
Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update.
Topics: Anti-Bacterial Agents; Australia; Buruli Ulcer; Debridement; Drug Therapy, Combination; Hot Temperature; Humans; Mycobacterium ulcerans; Practice Guidelines as Topic; Rifampin; Streptomycin | 2014 |
Buruli ulcer disease in Republic of the Congo.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Child, Preschool; Congo; Epidemiological Monitoring; Female; Humans; Male; Mycobacterium ulcerans; Neglected Diseases; Rifampin; Streptomycin | 2014 |
Compliance with antimicrobial therapy for buruli ulcer.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
Reply to "compliance with antimicrobial therapy for buruli ulcer".
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Female; Humans; Mycobacterium ulcerans; Rifampin; Streptomycin | 2014 |
In-vitro activity of avermectins against Mycobacterium ulcerans.
Topics: Administration, Oral; Buruli Ulcer; Ivermectin; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin; Streptomycin | 2015 |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Buruli Ulcer; Child; Child, Preschool; Coinfection; Disease Management; Female; Ghana; HIV Infections; Humans; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; World Health Organization; Young Adult | 2015 |
Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Endemic Diseases; Female; Ghana; Humans; Male; Mycobacterium ulcerans; Rifampin; Streptomycin; Young Adult | 2015 |
Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Ghana; Hospitals; Humans; Male; Medication Adherence; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome; Wound Healing; Young Adult | 2016 |
Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Female; Focus Groups; Ghana; Humans; Interviews as Topic; Male; Middle Aged; Mycobacterium ulcerans; Patient Preference; Rifampin; Streptomycin; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2016 |
Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Buruli Ulcer; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Ghana; Humans; Longitudinal Studies; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Wound Healing; Young Adult | 2016 |
New foci of Buruli ulcer, Angola and Democratic Republic of Congo.
Topics: Adolescent; Adult; Angola; Antibiotics, Antitubercular; Biopsy; Buruli Ulcer; Democratic Republic of the Congo; Diamond; Disease Reservoirs; Female; Humans; Male; Mining; Mycobacterium ulcerans; Rifampin; Risk Factors; Rivers; Skin; Streptomycin; Treatment Outcome | 2008 |
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Buruli Ulcer; Child; Female; Humans; Interferon-gamma; Interleukin-10; Male; Middle Aged; Mycobacterium ulcerans; Rifampin; Streptomycin | 2009 |
Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
Topics: Adolescent; Anti-Bacterial Agents; Buruli Ulcer; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Child; Drug Therapy, Combination; Female; Granuloma; Humans; Macrophages; Male; Middle Aged; Phagocytosis; Rifampin; Streptomycin; Treatment Outcome | 2009 |
Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2009 |
Buruli ulcer lesions in HIV-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Buruli Ulcer; Drug Therapy, Combination; Humans; Male; Rifampin; Streptomycin | 2010 |
Antimicrobial drugs for Buruli ulcer.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Ghana; Humans; Mice; Rifampin; Streptomycin | 2010 |
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteriological Techniques; Buruli Ulcer; Child; Child, Preschool; Cohort Studies; Democratic Republic of the Congo; Female; Histocytochemistry; Humans; Male; Middle Aged; Mycobacterium ulcerans; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome; Young Adult | 2010 |
Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Humans; Male; Osteomyelitis; Rifampin; Streptomycin | 2010 |
[Combined local and vaginal therapy in Buruli ulcer].
Topics: Adolescent; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Amikacin; Anti-Infective Agents; Buruli Ulcer; Child; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Humans; Metronidazole; Mycobacterium ulcerans; Osteomyelitis; Rifampin; Streptomycin | 2010 |
Buruli ulcer. A disabling infection.
Topics: Antitubercular Agents; Buruli Ulcer; Drug Therapy, Combination; Humans; Rifampin; Streptomycin; Water Microbiology | 2010 |
Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
Topics: Antibiotics, Antitubercular; Antigens, CD; Buruli Ulcer; Child; Humans; Immunohistochemistry; Leukocytes; Male; Mycobacterium ulcerans; Necrosis; Neglected Diseases; Rifampin; Skin; Streptomycin; Treatment Outcome | 2011 |
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Benin; Biopsy; Buruli Ulcer; Child; Child, Preschool; Debridement; Drug Therapy; Female; Histocytochemistry; Humans; Immunohistochemistry; Male; Microscopy; Middle Aged; Mycobacterium ulcerans; Rifampin; Skin; Streptomycin; Treatment Outcome; Young Adult | 2011 |
Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer.
Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Buruli Ulcer; Ghana; Health Care Costs; Humans; Microscopy; Mycobacterium ulcerans; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Streptomycin | 2011 |
Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Foot; Humans; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2012 |
Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Dexamethasone; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Flow Cytometry; Immunity, Cellular; Immunosuppressive Agents; Inflammation; Lymphocytes; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin | 2012 |
[Ghana: the experience in the land highly endemic for Buruli ulcer].
Topics: Buruli Ulcer; Communicable Disease Control; Drug Therapy, Combination; Early Diagnosis; Ghana; Humans; National Health Programs; Rifampin; Streptomycin; World Health Organization | 2012 |
Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; DNA Transposable Elements; DNA, Bacterial; Humans; Male; Mycobacterium ulcerans; Polymerase Chain Reaction; Streptomycin; Togo | 2012 |
Buruli ulcer in a nine-month-old boy.
Topics: Antitubercular Agents; Buruli Ulcer; Forearm; Humans; Infant; Male; Rifampin; Streptomycin | 2012 |
Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection.
Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Buruli Ulcer; Disease Models, Animal; Female; Foot; Histocytochemistry; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin; Treatment Outcome | 2012 |
Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin.
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child; Ghana; Granuloma; Humans; Immunohistochemistry; Lymphocytes; Mycobacterium; Mycobacterium Infections; Rifampin; Streptomycin | 2007 |